GO:0015152 glucose-6-phosphate transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015152 describes the molecular function of moving glucose-6-phosphate (G6P) across a membrane, typically as part of a sugar-phosphate/phosphate exchange mechanism.
• The founding member is the human glucose-6-phosphate transporter (G6PT, gene SLC37A4), an endoplasmic reticulum (ER) membrane protein that imports G6P into the ER lumen.
• G6PT deficiency causes glycogen storage disease type Ib (GSD-Ib), characterized by hypoglycemia, neutropenia, and neutrophil dysfunction.
• The transporter operates as a functional unit with glucose-6-phosphatase (G6Pase) to maintain blood glucose homeostasis via the final steps of gluconeogenesis and glycogenolysis.
• Structural and functional studies have identified critical residues and transmembrane topology required for G6P transport and protein stability.
• Research on GO:0015152 spans metabolic disorders, immune dysfunction, and cancer metabolism, with CRISPR models enabling precise functional dissection.
Description
Glucose-6-phosphate transmembrane transporter activity (GO:0015152) is a molecular function that enables the transfer of glucose-6-phosphate (G6P) from one side of a membrane to the other. This activity is essential for metabolic compartmentalization, particularly in the endoplasmic reticulum (ER), where G6P must be imported to be hydrolyzed by glucose-6-phosphatase (G6Pase) during the final steps of gluconeogenesis and glycogenolysis. The primary protein responsible for this activity in humans is the glucose-6-phosphate transporter (G6PT), encoded by the SLC37A4 gene, which functions as a sugar-phosphate/phosphate exchanger. Defects in G6PT cause glycogen storage disease type Ib (GSD-Ib), a metabolic disorder with severe clinical manifestations including hypoglycemia and neutropenia. Understanding the molecular mechanism, regulation, and pathophysiological roles of GO:0015152 is therefore critical for researchers in metabolism, immunology, and rare disease therapeutics.
glucose-6-phosphate transmembrane transporter activity At A Glance
| GO ID | GO:0015152 |
|---|---|
| GO term | glucose-6-phosphate transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Transfer of glucose-6-phosphate across a membrane |
| Major gene | SLC37A4 (G6PT) |
| Cellular location | Endoplasmic reticulum membrane |
| Associated disease | Glycogen storage disease type Ib |
| Mechanism | Sugar-phosphate/phosphate exchange |
What Is GO:0015152?
GO:0015152 is defined as enabling the transfer of glucose-6-phosphate from one side of a membrane to the other. Glucose-6-phosphate is a monophosphorylated derivative of glucose with the phosphate group attached to C-6. This activity is typically mediated by integral membrane proteins that facilitate the movement of G6P across cellular membranes, often in exchange for inorganic phosphate or other sugar phosphates.
Why Is glucose-6-phosphate transmembrane transporter activity Important in Cell Biology?
GO:0015152 is critical for metabolic homeostasis because it controls the access of glucose-6-phosphate to the ER lumen, where it is hydrolyzed to free glucose by G6Pase. This transport step is rate-limiting for the final common pathway of gluconeogenesis and glycogenolysis, and its dysfunction leads to life-threatening hypoglycemia and immune defects in GSD-Ib. Moreover, the transporter's role in maintaining ER G6P levels has implications for redox balance, protein folding, and cellular stress responses. Thus, studying this activity provides insights into metabolic regulation and disease mechanisms.
• Maintains blood glucose homeostasis by enabling ER G6P hydrolysis.
• Deficiency causes glycogen storage disease type Ib (GSD-Ib).
• G6PT is a member of the SLC37 family of sugar-phosphate/phosphate exchangers.
• G6P transport affects ER redox and calcium homeostasis.
• Modulates neutrophil function and immune response.
• Potential target for metabolic disorders and cancer therapy.
• Essential for hepatic glucose production during fasting.
• Provides a model for studying membrane transport mechanisms.
• Links to mitochondrial function via CFTR activity.
• Enables compartmentalized metabolic studies using CRISPR models.
Molecular Mechanism of glucose-6-phosphate transmembrane transporter activity
Substrate Recognition and Binding
In simple terms: The transporter recognizes and binds glucose-6-phosphate on one side of the membrane.
G6PT specifically binds glucose-6-phosphate (G6P) with high affinity, distinguishing it from other sugar phosphates. Structural studies suggest that the transmembrane domains form a binding pocket that accommodates the phosphorylated sugar. Critical residues within the transporter are required for substrate binding and subsequent transport activity.
Transmembrane Translocation
In simple terms: The bound G6P is moved across the membrane through a conformational change.
Upon binding, the transporter undergoes conformational changes that allow G6P to traverse the lipid bilayer. The transport process is thought to involve an alternating access mechanism, where the substrate-binding site is exposed alternately to the cytoplasm and the ER lumen. This step is energy-independent, driven by concentration gradients or exchange with phosphate.
Phosphate Exchange and Coupling
In simple terms: The transporter often exchanges G6P for phosphate or other sugar phosphates.
G6PT functions as a sugar-phosphate/phosphate exchanger, meaning that the inward transport of G6P is coupled to the outward movement of inorganic phosphate (Pi) or another sugar phosphate. This exchange mechanism ensures electroneutrality and maintains the driving force for continued transport. The stoichiometry and specificity of exchange have been characterized in microsomal systems.
Regulation by Protein Interactions
In simple terms: The transporter's activity can be modulated by interacting proteins.
G6PT interacts with glucose-6-phosphatase (G6Pase) in the ER membrane, forming a functional complex that couples G6P transport to hydrolysis. This interaction is essential for efficient glucose production, and disruption of the complex leads to metabolic dysfunction. Additionally, CFTR activity has been linked to mitochondrial function and may indirectly influence G6P transport.
Structural Determinants of Function
In simple terms: Specific parts of the transporter protein are required for its stability and activity.
Mutational analyses have identified transmembrane helices and conserved residues critical for G6PT stability and transport activity. For example, the N-terminus and specific loops are important for proper folding and ER retention. Disease-causing mutations in SLC37A4 often affect these structural elements, leading to loss of function.
Key Genes Involved in GO:0015152 glucose-6-phosphate transmembrane transporter activity
The following genes and proteins are directly involved in glucose-6-phosphate transmembrane transporter activity or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC37A4 | Encodes G6PT, the primary G6P transporter | Mutations cause GSD-Ib; target for functional studies |
| G6PC1 | Glucose-6-phosphatase catalytic subunit | Partners with G6PT for glucose production |
| G6PC2 | Islet-specific glucose-6-phosphatase | May interact with G6PT in pancreatic beta cells |
| SLC37A1 | Related sugar-phosphate transporter | Potential functional redundancy |
| SLC37A2 | Related sugar-phosphate transporter | Expressed in macrophages; role in immunity |
| SLC37A3 | Related sugar-phosphate transporter | Less characterized; possible G6P transport |
| CFTR | Chloride channel; modulates mitochondrial function | Indirectly affects G6P transport via redox |
| UhpC | Bacterial G6P sensor/transporter | Model for G6P-dependent signaling |
| UhpB | Bacterial histidine kinase | Part of Uhp two-component system |
| UhpA | Bacterial response regulator | Regulates G6P-dependent gene expression |
| G6PT (protein) | Human G6P transporter | Direct subject of structural and functional studies |
| G6Pase (protein) | Glucose-6-phosphatase | Functional partner in ER |
| SLC37A4 variants | Mutant forms of G6PT | Used to study GSD-Ib mechanisms |
| ER membrane proteins | Chaperones and interactors | Modulate G6PT stability |
| Phosphate transporters | Provide Pi for exchange | Coupled to G6P transport |
| Neutrophil proteins | Affected by G6PT deficiency | Link to immune dysfunction |
| Metabolic enzymes | Downstream of G6P | Integrate transport with metabolism |
How Is glucose-6-phosphate transmembrane transporter activity Regulated?
The activity of glucose-6-phosphate transmembrane transporter is regulated at multiple levels. Transcriptional regulation of SLC37A4 responds to metabolic status, such as fasting and hormonal signals. Post-translational modifications and protein-protein interactions, particularly with G6Pase, modulate transport efficiency. Additionally, the transporter's activity is influenced by the redox state of the ER and mitochondrial function, as CFTR activity affects mitochondrial metabolism and may indirectly impact G6P transport. In bacteria, the Uhp two-component system senses external G6P and regulates expression of transport and metabolic genes.
glucose-6-phosphate transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC37A4 | Glycogen storage disease type Ib | Knockout mouse, patient-derived iPSCs |
| SLC37A4 | Neutropenia and immune dysfunction | Conditional knockout in hematopoietic cells |
| G6PC1 | Glycogen storage disease type Ia | Liver-specific knockout |
| CFTR | Cystic fibrosis-related metabolic defects | CFTR knockout models |
| UhpC | Bacterial G6P sensing | Bacterial knockout and reporter assays |
Glycogen Storage Disease Type Ib (GSD-Ib)
Mutations in SLC37A4, which encodes the glucose-6-phosphate transporter, cause GSD-Ib, an autosomal recessive metabolic disorder. Patients present with hypoglycemia, hepatomegaly, and neutropenia, leading to recurrent infections. The disease results from impaired G6P transport into the ER, disrupting glucose production and neutrophil function.
Neutrophil Dysfunction and Immune Deficiency
G6PT deficiency in GSD-Ib leads to neutropenia and impaired neutrophil function, including defects in chemotaxis and respiratory burst. The exact mechanisms involve ER stress and altered energy metabolism in neutrophils. This highlights the importance of G6P transport in immune cells beyond liver metabolism.
Cancer Metabolism and Chemoresistance
Altered glucose-6-phosphate transport may contribute to cancer cell metabolism by affecting ER stress and redox balance. Although direct evidence is limited, the transporter's role in maintaining ER homeostasis suggests potential implications in tumor progression and chemoresistance.
From glucose-6-phosphate transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC37A4 loss affect glucose homeostasis? | Liver-specific knockout mouse |
| What is the role of G6PT in neutrophils? | Conditional knockout in myeloid lineage |
| How do point mutations in SLC37A4 affect transport? | Point-mutation knock-in cell lines |
| Can wild-type G6PT rescue GSD-Ib phenotypes? | Knock-in of wild-type SLC37A4 in patient cells |
| What proteins interact with G6PT? | Tagged knock-in for affinity purification |
| Does G6PT overexpression alter ER stress? | Overexpression in hepatoma cell lines |
How to Study the glucose-6-phosphate transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Microsomal transport assay | G6P uptake into ER vesicles | Measuring G6PT activity |
| Protease protection | Transmembrane topology | Determining membrane orientation |
| Site-directed mutagenesis | Effect of mutations on transport | Mapping functional residues |
| Complementation assay | Rescue of transport defect | Validating disease mutations |
| CRISPR knockout | Loss-of-function phenotypes | Studying GSD-Ib mechanisms |
| CRISPR knock-in | Expression of mutant or tagged protein | Structure-function studies |
| RNA-seq | Transcriptional changes | Identifying pathways affected by G6PT loss |
| Proteomics | Protein interactions | Finding G6PT partners |
Transport Assays
Microsomal transport assays using radiolabeled G6P are standard for measuring G6PT activity. These assays can be performed with isolated ER vesicles from cells or tissues, and are used to assess the impact of mutations or inhibitors.
Structural and Topological Analysis
Transmembrane topology can be determined using protease protection assays, glycosylation mapping, and cysteine accessibility studies. These methods reveal the orientation of transmembrane helices and identify critical residues for function.
Mutagenesis and Functional Complementation
Site-directed mutagenesis combined with transport assays in G6PT-deficient cells allows functional mapping of disease-causing mutations. Complementation with wild-type or mutant SLC37A4 can rescue transport defects and provide insights into structure-function relationships.
CRISPR-Based Genetic Models
CRISPR/Cas9 knockout, knock-in, and point-mutation models enable precise dissection of G6PT function in relevant cell types, such as hepatocytes and neutrophils. These models are essential for studying disease mechanisms and testing therapeutic strategies.
How CRISPR Can Be Used to Study GO:0015152 glucose-6-phosphate transmembrane transporter activity
Knockout
CRISPR knockout of SLC37A4 in cell lines or animal models recapitulates GSD-Ib phenotypes, including impaired glucose production and neutrophil dysfunction. These models are used to study the metabolic and immune consequences of G6PT deficiency and to test potential therapies.
Point Mutation
Introducing specific disease-causing point mutations into SLC37A4 via CRISPR allows researchers to dissect the functional impact of individual variants on transport activity and protein stability. This approach is valuable for genotype-phenotype correlations in GSD-Ib.
Knock-in
Knock-in of wild-type or tagged SLC37A4 enables rescue experiments and protein interaction studies. Tagged knock-in models facilitate localization and affinity purification of the transporter complex.
Overexpression
CRISPR-mediated overexpression of SLC37A4 or its variants can be used to study gain-of-function effects, ER stress modulation, and interactions with G6Pase. Overexpression models help identify downstream pathways affected by altered G6P transport.
How EDITGENE Supports glucose-6-phosphate transmembrane transporter activity Research
Researchers studying glucose-6-phosphate transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell and animal models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for glucose-6-phosphate transmembrane transporter activity research.
Frequently Asked Questions About glucose-6-phosphate transmembrane transporter activity
What is glucose-6-phosphate transmembrane transporter activity?
It is a molecular function (GO:0015152) that enables the movement of glucose-6-phosphate across a membrane, typically in the endoplasmic reticulum.
What genes are involved in glucose-6-phosphate transmembrane transporter activity?
The primary gene is SLC37A4, which encodes the glucose-6-phosphate transporter (G6PT). Related genes include SLC37A1, SLC37A2, and SLC37A3.
What diseases are associated with glucose-6-phosphate transmembrane transporter activity?
Deficiency causes glycogen storage disease type Ib (GSD-Ib), characterized by hypoglycemia and neutropenia.
How is glucose-6-phosphate transported across the ER membrane?
G6PT functions as a sugar-phosphate/phosphate exchanger, moving G6P into the ER lumen in exchange for phosphate.
What is the role of SLC37A4 in metabolism?
SLC37A4 enables G6P transport into the ER for hydrolysis by G6Pase, the final step of gluconeogenesis and glycogenolysis.
Can CRISPR be used to study glucose-6-phosphate transport?
Yes, CRISPR knockout, knock-in, and point-mutation models are powerful tools to dissect G6PT function and disease mechanisms.
What are the symptoms of GSD-Ib?
Symptoms include hypoglycemia, hepatomegaly, neutropenia, and recurrent infections.
How is G6PT activity measured?
Microsomal transport assays using radiolabeled G6P are commonly used to measure G6PT activity.
What is the structure of the glucose-6-phosphate transporter?
G6PT is an integral membrane protein with multiple transmembrane helices, and its topology has been characterized.
Are there animal models for GSD-Ib?
Yes, knockout mouse models of SLC37A4 recapitulate key features of GSD-Ib and are used for preclinical studies.
Conclusion
Glucose-6-phosphate transmembrane transporter activity (GO:0015152) is a fundamental molecular function required for metabolic compartmentalization and glucose homeostasis. The SLC37A4-encoded transporter G6PT is the key mediator of this activity, and its dysfunction leads to GSD-Ib. Ongoing research using CRISPR models and advanced biochemical assays continues to elucidate the mechanism, regulation, and therapeutic potential of this transporter.
References
- 1. Pan CJ et al.. 1999. Transmembrane topology of human glucose 6-phosphate transporter.. J Biol Chem 274(20):13865-9 PMID: 10318794
- 2. Chen LY et al.. 2000. Structural requirements for the stability and microsomal transport activity of the human glucose 6-phosphate transporter.. J Biol Chem 275(44):34280-6 PMID: 10940311
- 3. Chou JY et al.. 2014. The SLC37 family of sugar-phosphate/phosphate exchangers.. Curr Top Membr 73:357-82 PMID: 24745989
- 4. Lin B et al.. 2000. Human variant glucose-6-phosphate transporter is active in microsomal transport.. Hum Genet 107(5):526-9 PMID: 11140953
- 5. Valdivieso AG et al.. 2013. CFTR activity and mitochondrial function.. Redox Biol 1(1):190-202 PMID: 24024153
- 6. Bánhegyi G et al.. 1997. Demonstration of a metabolically active glucose-6-phosphate pool in the lumen of liver microsomal vesicles.. J Biol Chem 272(21):13584-90 PMID: 9153206
- 7. Verhamme DT et al.. 2001. Glucose-6-phosphate-dependent phosphoryl flow through the Uhp two-component regulatory system.. Microbiology (Reading) 147(Pt 12):3345-52 PMID: 11739766
- 8. Chen LY et al.. 2002. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.. Hum Mol Genet 11(25):3199-207 PMID: 12444104
